ClinicalTrials.govpublic full text
MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)
malignant neoplasm of respiratory and intrathoracic organ carcinoma, advanced lung cancer, recurrent nonsmall cell lung cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 238109
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.